Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera
This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions...